Shire plc was a global biopharmaceutical company focused on developing and commercializing treatments for rare diseases and other specialty conditions. Headquartered in the United Kingdom, the company specialized in areas such as hematology, immunology, neuroscience, and genetic diseases.
Shire was acquired by Takeda Pharmaceutical Company in 2019 and is no longer an independent entity. Its portfolio and operations have been integrated into Takeda’s rare disease and specialty care businesses.
Official website: shire.com
To provide comprehensive coverage, we aggregate data and news under the name Shire, encompassing the following company names, divisions, and related entities:
Shire Pharmaceuticals.
This list encompasses current and former names, alternate names, and key divisions associated with Shire, ensuring you can easily find all relevant information under a single, unified profile.
